Cargando…

Future costs in cost-effectiveness analysis: an empirical assessment

AIM: The aim of this study was to assess the impact on the cost-effectiveness ratio of including measures of production and consumption following a health care or health promotion intervention that improves survival. DATA AND METHODS: We defined the net incremental consumption, or future costs, as t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruse, Marie, Sørensen, Jan, Gyrd-Hansen, Dorte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249583/
https://www.ncbi.nlm.nih.gov/pubmed/20878202
http://dx.doi.org/10.1007/s10198-010-0280-0
_version_ 1782220357450596352
author Kruse, Marie
Sørensen, Jan
Gyrd-Hansen, Dorte
author_facet Kruse, Marie
Sørensen, Jan
Gyrd-Hansen, Dorte
author_sort Kruse, Marie
collection PubMed
description AIM: The aim of this study was to assess the impact on the cost-effectiveness ratio of including measures of production and consumption following a health care or health promotion intervention that improves survival. DATA AND METHODS: We defined the net incremental consumption, or future costs, as the change in consumption minus change in production, while differentiating between health care and non-health care consumption. Based on 2005 register-based data for the entire Danish population, we estimated the average value of annual production and consumption for 1-year age groups. We computed the net consumption in the remaining expected lifetime and the net consumption per life year gained for different age groups. RESULTS: Age has a profound effect on the magnitude of net consumption. When including net incremental consumption in the cost-effectiveness ratio of a health care or health promotion intervention, the relative cost-effectiveness changed up to €21,000 across age groups. The largest difference in the cost-effectiveness ratio was observed among the 30-year-olds where costs were reduced significantly due to significant future net contributions to society. CONCLUSION: This paper contains cost figures for use in cost-effectiveness analyses, when the societal perspective is adopted and future consumption and production effects are taken into account. The net consumption varies considerably with age. Inclusion of net incremental consumption in the cost-effectiveness analysis will markedly affect the relative cost-effectiveness of interventions targeted at different age groups. Omitting future cost from cost-effectiveness analysis may bias the ranking of health care interventions and favour interventions aimed at older age groups. We used Danish data for this assessment, and our results will therefore not represent true figures for other countries. We do, however, believe that the overall impact of including net production value in CEA will be similar in other countries that have similar transfers of income from the younger age groups to older age groups as well as publicly financed social and health care services.
format Online
Article
Text
id pubmed-3249583
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-32495832012-01-11 Future costs in cost-effectiveness analysis: an empirical assessment Kruse, Marie Sørensen, Jan Gyrd-Hansen, Dorte Eur J Health Econ Original Paper AIM: The aim of this study was to assess the impact on the cost-effectiveness ratio of including measures of production and consumption following a health care or health promotion intervention that improves survival. DATA AND METHODS: We defined the net incremental consumption, or future costs, as the change in consumption minus change in production, while differentiating between health care and non-health care consumption. Based on 2005 register-based data for the entire Danish population, we estimated the average value of annual production and consumption for 1-year age groups. We computed the net consumption in the remaining expected lifetime and the net consumption per life year gained for different age groups. RESULTS: Age has a profound effect on the magnitude of net consumption. When including net incremental consumption in the cost-effectiveness ratio of a health care or health promotion intervention, the relative cost-effectiveness changed up to €21,000 across age groups. The largest difference in the cost-effectiveness ratio was observed among the 30-year-olds where costs were reduced significantly due to significant future net contributions to society. CONCLUSION: This paper contains cost figures for use in cost-effectiveness analyses, when the societal perspective is adopted and future consumption and production effects are taken into account. The net consumption varies considerably with age. Inclusion of net incremental consumption in the cost-effectiveness analysis will markedly affect the relative cost-effectiveness of interventions targeted at different age groups. Omitting future cost from cost-effectiveness analysis may bias the ranking of health care interventions and favour interventions aimed at older age groups. We used Danish data for this assessment, and our results will therefore not represent true figures for other countries. We do, however, believe that the overall impact of including net production value in CEA will be similar in other countries that have similar transfers of income from the younger age groups to older age groups as well as publicly financed social and health care services. Springer-Verlag 2010-09-28 2012 /pmc/articles/PMC3249583/ /pubmed/20878202 http://dx.doi.org/10.1007/s10198-010-0280-0 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Paper
Kruse, Marie
Sørensen, Jan
Gyrd-Hansen, Dorte
Future costs in cost-effectiveness analysis: an empirical assessment
title Future costs in cost-effectiveness analysis: an empirical assessment
title_full Future costs in cost-effectiveness analysis: an empirical assessment
title_fullStr Future costs in cost-effectiveness analysis: an empirical assessment
title_full_unstemmed Future costs in cost-effectiveness analysis: an empirical assessment
title_short Future costs in cost-effectiveness analysis: an empirical assessment
title_sort future costs in cost-effectiveness analysis: an empirical assessment
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249583/
https://www.ncbi.nlm.nih.gov/pubmed/20878202
http://dx.doi.org/10.1007/s10198-010-0280-0
work_keys_str_mv AT krusemarie futurecostsincosteffectivenessanalysisanempiricalassessment
AT sørensenjan futurecostsincosteffectivenessanalysisanempiricalassessment
AT gyrdhansendorte futurecostsincosteffectivenessanalysisanempiricalassessment